Muhdo Health are delighted to be part of the PREDICTOM and Horizon study with regards to genetic and epigenetic markers surrounding the development of Alzheimer’s, which is titled: “Improve access to existing and discover new biomarkers for early detection of cognitive decline” This aims to develop novel biomarkers for extracting the most relevant features for […]